nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Microtubule Inhibition—Paclitaxel—ovarian cancer	0.159	0.58	CiPCiCtD
Cabazitaxel—Paclitaxel—ovarian cancer	0.148	0.58	CrCtD
Cabazitaxel—Microtubule Inhibition—Docetaxel—ovarian cancer	0.115	0.42	CiPCiCtD
Cabazitaxel—Docetaxel—ovarian cancer	0.107	0.42	CrCtD
Cabazitaxel—Docetaxel—Paclitaxel—ovarian cancer	0.0866	0.58	CrCrCtD
Cabazitaxel—TUBB3—ovarian cancer	0.0863	0.886	CbGaD
Cabazitaxel—Paclitaxel—Docetaxel—ovarian cancer	0.0626	0.419	CrCrCtD
Cabazitaxel—ABCB1—ovarian cancer	0.0111	0.114	CbGaD
Cabazitaxel—TUBB4A—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB3—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB6—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB2A—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB8—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB2B—Vinorelbine—ovarian cancer	0.00824	0.049	CbGbCtD
Cabazitaxel—TUBB—Vinorelbine—ovarian cancer	0.0069	0.041	CbGbCtD
Cabazitaxel—TUBB1—Vinorelbine—ovarian cancer	0.0069	0.041	CbGbCtD
Cabazitaxel—TUBB4B—Vinorelbine—ovarian cancer	0.0069	0.041	CbGbCtD
Cabazitaxel—TUBB2A—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB6—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB8—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB2B—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB4A—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB3—Paclitaxel—ovarian cancer	0.00579	0.0344	CbGbCtD
Cabazitaxel—TUBB—Paclitaxel—ovarian cancer	0.00484	0.0288	CbGbCtD
Cabazitaxel—TUBB1—Paclitaxel—ovarian cancer	0.00484	0.0288	CbGbCtD
Cabazitaxel—TUBB4B—Paclitaxel—ovarian cancer	0.00484	0.0288	CbGbCtD
Cabazitaxel—TUBB2A—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB6—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB8—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB2B—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB3—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB4A—Docetaxel—ovarian cancer	0.00419	0.0249	CbGbCtD
Cabazitaxel—TUBB—Docetaxel—ovarian cancer	0.0035	0.0208	CbGbCtD
Cabazitaxel—TUBB1—Docetaxel—ovarian cancer	0.0035	0.0208	CbGbCtD
Cabazitaxel—TUBB4B—Docetaxel—ovarian cancer	0.0035	0.0208	CbGbCtD
Cabazitaxel—SLCO1B3—Paclitaxel—ovarian cancer	0.00207	0.0123	CbGbCtD
Cabazitaxel—ABCG2—Topotecan—ovarian cancer	0.00193	0.0115	CbGbCtD
Cabazitaxel—SLCO1B3—Docetaxel—ovarian cancer	0.00149	0.00889	CbGbCtD
Cabazitaxel—ABCG2—Paclitaxel—ovarian cancer	0.000956	0.00569	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—ovarian cancer	0.0009	0.00535	CbGbCtD
Cabazitaxel—ABCB1—Topotecan—ovarian cancer	0.000697	0.00414	CbGbCtD
Cabazitaxel—ABCG2—Docetaxel—ovarian cancer	0.000691	0.00411	CbGbCtD
Cabazitaxel—CYP3A5—Paclitaxel—ovarian cancer	0.00053	0.00315	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—ovarian cancer	0.000515	0.00307	CbGbCtD
Cabazitaxel—CYP2C8—Paclitaxel—ovarian cancer	0.000509	0.00303	CbGbCtD
Cabazitaxel—ABCB1—Vinorelbine—ovarian cancer	0.000491	0.00292	CbGbCtD
Cabazitaxel—TUBB4B—oviduct—ovarian cancer	0.000477	0.0391	CbGeAlD
Cabazitaxel—CYP3A4—Topotecan—ovarian cancer	0.000417	0.00248	CbGbCtD
Cabazitaxel—CYP3A5—Docetaxel—ovarian cancer	0.000383	0.00228	CbGbCtD
Cabazitaxel—ABCB1—Paclitaxel—ovarian cancer	0.000345	0.00205	CbGbCtD
Cabazitaxel—CYP3A4—Vinorelbine—ovarian cancer	0.000294	0.00175	CbGbCtD
Cabazitaxel—Paclitaxel—TUBB3—ovarian cancer	0.000288	0.28	CrCbGaD
Cabazitaxel—Docetaxel—TUBB3—ovarian cancer	0.000288	0.28	CrCbGaD
Cabazitaxel—ABCB1—Docetaxel—ovarian cancer	0.000249	0.00148	CbGbCtD
Cabazitaxel—TUBA4A—myometrium—ovarian cancer	0.000244	0.02	CbGeAlD
Cabazitaxel—TUBB1—decidua—ovarian cancer	0.000233	0.0191	CbGeAlD
Cabazitaxel—TUBB8—testis—ovarian cancer	0.000222	0.0182	CbGeAlD
Cabazitaxel—CYP3A4—Paclitaxel—ovarian cancer	0.000207	0.00123	CbGbCtD
Cabazitaxel—TUBA4A—epithelium—ovarian cancer	0.000191	0.0157	CbGeAlD
Cabazitaxel—TUBA4A—uterine cervix—ovarian cancer	0.00019	0.0156	CbGeAlD
Cabazitaxel—TUBB2B—myometrium—ovarian cancer	0.000189	0.0155	CbGeAlD
Cabazitaxel—TUBB4A—embryo—ovarian cancer	0.000188	0.0154	CbGeAlD
Cabazitaxel—ABCB1—Doxorubicin—ovarian cancer	0.000186	0.00111	CbGbCtD
Cabazitaxel—TUBA4A—decidua—ovarian cancer	0.000181	0.0148	CbGeAlD
Cabazitaxel—TUBB—myometrium—ovarian cancer	0.000179	0.0147	CbGeAlD
Cabazitaxel—TUBB2A—myometrium—ovarian cancer	0.000178	0.0146	CbGeAlD
Cabazitaxel—TUBB6—myometrium—ovarian cancer	0.000175	0.0144	CbGeAlD
Cabazitaxel—TUBB1—bone marrow—ovarian cancer	0.000173	0.0142	CbGeAlD
Cabazitaxel—TUBA4A—endometrium—ovarian cancer	0.000172	0.0141	CbGeAlD
Cabazitaxel—TUBA4A—gonad—ovarian cancer	0.000159	0.0131	CbGeAlD
Cabazitaxel—TUBA4A—uterus—ovarian cancer	0.000158	0.013	CbGeAlD
Cabazitaxel—TUBB4B—myometrium—ovarian cancer	0.000152	0.0125	CbGeAlD
Cabazitaxel—TUBB4A—uterine cervix—ovarian cancer	0.000152	0.0125	CbGeAlD
Cabazitaxel—TUBB3—testis—ovarian cancer	0.000151	0.0124	CbGeAlD
Cabazitaxel—CYP3A4—Docetaxel—ovarian cancer	0.000149	0.000888	CbGbCtD
Cabazitaxel—SLCO1B3—vagina—ovarian cancer	0.000148	0.0122	CbGeAlD
Cabazitaxel—TUBB1—testis—ovarian cancer	0.000148	0.0121	CbGeAlD
Cabazitaxel—TUBB2B—uterine cervix—ovarian cancer	0.000147	0.0121	CbGeAlD
Cabazitaxel—TUBB4B—embryo—ovarian cancer	0.000147	0.012	CbGeAlD
Cabazitaxel—TUBA4A—female reproductive system—ovarian cancer	0.000142	0.0117	CbGeAlD
Cabazitaxel—TUBB—uterine cervix—ovarian cancer	0.000139	0.0114	CbGeAlD
Cabazitaxel—TUBB2A—uterine cervix—ovarian cancer	0.000138	0.0114	CbGeAlD
Cabazitaxel—TUBB6—epithelium—ovarian cancer	0.000138	0.0113	CbGeAlD
Cabazitaxel—TUBB6—uterine cervix—ovarian cancer	0.000137	0.0112	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—ovarian cancer	0.000134	0.011	CbGeAlD
Cabazitaxel—TUBB2B—endometrium—ovarian cancer	0.000133	0.0109	CbGeAlD
Cabazitaxel—TUBB—decidua—ovarian cancer	0.000133	0.0109	CbGeAlD
Cabazitaxel—TUBB2A—decidua—ovarian cancer	0.000132	0.0108	CbGeAlD
Cabazitaxel—TUBB6—decidua—ovarian cancer	0.00013	0.0107	CbGeAlD
Cabazitaxel—TUBA4A—female gonad—ovarian cancer	0.000129	0.0106	CbGeAlD
Cabazitaxel—Paclitaxel—CYP1B1—ovarian cancer	0.000129	0.125	CrCbGaD
Cabazitaxel—Docetaxel—CYP1B1—ovarian cancer	0.000129	0.125	CrCbGaD
Cabazitaxel—TUBA4A—vagina—ovarian cancer	0.000129	0.0106	CbGeAlD
Cabazitaxel—TUBB4A—gonad—ovarian cancer	0.000128	0.0105	CbGeAlD
Cabazitaxel—TUBB4A—uterus—ovarian cancer	0.000127	0.0104	CbGeAlD
Cabazitaxel—TUBB—endometrium—ovarian cancer	0.000126	0.0103	CbGeAlD
Cabazitaxel—TUBB2A—endometrium—ovarian cancer	0.000125	0.0103	CbGeAlD
Cabazitaxel—TUBB6—endometrium—ovarian cancer	0.000123	0.0101	CbGeAlD
Cabazitaxel—TUBB2B—gonad—ovarian cancer	0.000123	0.0101	CbGeAlD
Cabazitaxel—Docetaxel—EGFR—ovarian cancer	0.000122	0.118	CrCbGaD
Cabazitaxel—TUBB4B—uterine cervix—ovarian cancer	0.000119	0.00974	CbGeAlD
Cabazitaxel—TUBB—uterus—ovarian cancer	0.000116	0.00952	CbGeAlD
Cabazitaxel—TUBB2A—uterus—ovarian cancer	0.000115	0.00947	CbGeAlD
Cabazitaxel—TUBA4A—testis—ovarian cancer	0.000115	0.00942	CbGeAlD
Cabazitaxel—TUBB6—gonad—ovarian cancer	0.000115	0.0094	CbGeAlD
Cabazitaxel—TUBB4A—female reproductive system—ovarian cancer	0.000114	0.00936	CbGeAlD
Cabazitaxel—TUBB6—uterus—ovarian cancer	0.000114	0.00934	CbGeAlD
Cabazitaxel—TUBB4B—decidua—ovarian cancer	0.000113	0.00928	CbGeAlD
Cabazitaxel—CYP3A4—Doxorubicin—ovarian cancer	0.000111	0.000662	CbGbCtD
Cabazitaxel—TUBB2B—female reproductive system—ovarian cancer	0.00011	0.00905	CbGeAlD
Cabazitaxel—TUBB4B—endometrium—ovarian cancer	0.000107	0.00881	CbGeAlD
Cabazitaxel—TUBB4A—female gonad—ovarian cancer	0.000104	0.00852	CbGeAlD
Cabazitaxel—TUBB2A—female reproductive system—ovarian cancer	0.000104	0.00851	CbGeAlD
Cabazitaxel—TUBB6—female reproductive system—ovarian cancer	0.000102	0.0084	CbGeAlD
Cabazitaxel—TUBB2B—female gonad—ovarian cancer	0.0001	0.00823	CbGeAlD
Cabazitaxel—TUBB2B—vagina—ovarian cancer	9.96e-05	0.00818	CbGeAlD
Cabazitaxel—TUBB4B—gonad—ovarian cancer	9.95e-05	0.00817	CbGeAlD
Cabazitaxel—TUBB4B—uterus—ovarian cancer	9.89e-05	0.00812	CbGeAlD
Cabazitaxel—TUBB—bone marrow—ovarian cancer	9.84e-05	0.00808	CbGeAlD
Cabazitaxel—TUBB2A—bone marrow—ovarian cancer	9.79e-05	0.00804	CbGeAlD
Cabazitaxel—TUBB6—bone marrow—ovarian cancer	9.66e-05	0.00793	CbGeAlD
Cabazitaxel—TUBB—female gonad—ovarian cancer	9.49e-05	0.00779	CbGeAlD
Cabazitaxel—SLCO1B1—female reproductive system—ovarian cancer	9.48e-05	0.00779	CbGeAlD
Cabazitaxel—TUBB2A—female gonad—ovarian cancer	9.44e-05	0.00775	CbGeAlD
Cabazitaxel—TUBB—vagina—ovarian cancer	9.43e-05	0.00774	CbGeAlD
Cabazitaxel—TUBB2A—vagina—ovarian cancer	9.38e-05	0.0077	CbGeAlD
Cabazitaxel—TUBB6—female gonad—ovarian cancer	9.31e-05	0.00764	CbGeAlD
Cabazitaxel—TUBB6—vagina—ovarian cancer	9.25e-05	0.00759	CbGeAlD
Cabazitaxel—TUBB4A—testis—ovarian cancer	9.2e-05	0.00755	CbGeAlD
Cabazitaxel—ABCG2—myometrium—ovarian cancer	8.99e-05	0.00738	CbGeAlD
Cabazitaxel—TUBB2B—testis—ovarian cancer	8.89e-05	0.0073	CbGeAlD
Cabazitaxel—TUBB4B—female reproductive system—ovarian cancer	8.89e-05	0.0073	CbGeAlD
Cabazitaxel—TUBB—testis—ovarian cancer	8.41e-05	0.00691	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—ovarian cancer	8.39e-05	0.00689	CbGeAlD
Cabazitaxel—TUBB2A—testis—ovarian cancer	8.37e-05	0.00687	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—ovarian cancer	8.32e-05	0.00683	CbGeAlD
Cabazitaxel—TUBB6—testis—ovarian cancer	8.25e-05	0.00678	CbGeAlD
Cabazitaxel—TUBB4B—female gonad—ovarian cancer	8.09e-05	0.00664	CbGeAlD
Cabazitaxel—TUBB4B—vagina—ovarian cancer	8.04e-05	0.0066	CbGeAlD
Cabazitaxel—TUBB4B—testis—ovarian cancer	7.17e-05	0.00589	CbGeAlD
Cabazitaxel—ABCG2—uterine cervix—ovarian cancer	7e-05	0.00575	CbGeAlD
Cabazitaxel—ABCG2—decidua—ovarian cancer	6.67e-05	0.00547	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—ovarian cancer	6.67e-05	0.00547	CbGeAlD
Cabazitaxel—CYP2C8—endometrium—ovarian cancer	6.51e-05	0.00535	CbGeAlD
Cabazitaxel—CYP3A5—uterine cervix—ovarian cancer	6.5e-05	0.00533	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—ovarian cancer	6.44e-05	0.00529	CbGeAlD
Cabazitaxel—ABCG2—endometrium—ovarian cancer	6.33e-05	0.0052	CbGeAlD
Cabazitaxel—TUBB—lymph node—ovarian cancer	6.1e-05	0.00501	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—ovarian cancer	6.07e-05	0.00498	CbGeAlD
Cabazitaxel—TUBB6—lymph node—ovarian cancer	5.98e-05	0.00491	CbGeAlD
Cabazitaxel—ABCG2—uterus—ovarian cancer	5.83e-05	0.00479	CbGeAlD
Cabazitaxel—CYP2C8—female reproductive system—ovarian cancer	5.39e-05	0.00443	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—ovarian cancer	5.2e-05	0.00427	CbGeAlD
Cabazitaxel—ABCG2—bone marrow—ovarian cancer	4.95e-05	0.00406	CbGeAlD
Cabazitaxel—CYP2C8—vagina—ovarian cancer	4.88e-05	0.004	CbGeAlD
Cabazitaxel—ABCG2—female gonad—ovarian cancer	4.77e-05	0.00392	CbGeAlD
Cabazitaxel—ABCG2—vagina—ovarian cancer	4.74e-05	0.00389	CbGeAlD
Cabazitaxel—ABCB1—myometrium—ovarian cancer	4.43e-05	0.00364	CbGeAlD
Cabazitaxel—CYP3A5—female gonad—ovarian cancer	4.43e-05	0.00364	CbGeAlD
Cabazitaxel—CYP3A5—vagina—ovarian cancer	4.4e-05	0.00361	CbGeAlD
Cabazitaxel—CYP2C8—testis—ovarian cancer	4.35e-05	0.00357	CbGeAlD
Cabazitaxel—ABCB1—embryo—ovarian cancer	4.27e-05	0.0035	CbGeAlD
Cabazitaxel—ABCG2—testis—ovarian cancer	4.23e-05	0.00347	CbGeAlD
Cabazitaxel—Docetaxel—ABCB1—ovarian cancer	3.7e-05	0.0359	CrCbGaD
Cabazitaxel—Paclitaxel—ABCB1—ovarian cancer	3.7e-05	0.0359	CrCbGaD
Cabazitaxel—CYP3A4—female reproductive system—ovarian cancer	3.65e-05	0.003	CbGeAlD
Cabazitaxel—ABCB1—epithelium—ovarian cancer	3.48e-05	0.00286	CbGeAlD
Cabazitaxel—ABCB1—uterine cervix—ovarian cancer	3.45e-05	0.00283	CbGeAlD
Cabazitaxel—ABCB1—decidua—ovarian cancer	3.29e-05	0.0027	CbGeAlD
Cabazitaxel—ABCB1—endometrium—ovarian cancer	3.12e-05	0.00256	CbGeAlD
Cabazitaxel—ABCG2—lymph node—ovarian cancer	3.07e-05	0.00252	CbGeAlD
Cabazitaxel—ABCB1—gonad—ovarian cancer	2.9e-05	0.00238	CbGeAlD
Cabazitaxel—ABCB1—uterus—ovarian cancer	2.88e-05	0.00236	CbGeAlD
Cabazitaxel—ABCB1—female reproductive system—ovarian cancer	2.59e-05	0.00212	CbGeAlD
Cabazitaxel—ABCB1—bone marrow—ovarian cancer	2.44e-05	0.002	CbGeAlD
Cabazitaxel—ABCB1—female gonad—ovarian cancer	2.35e-05	0.00193	CbGeAlD
Cabazitaxel—ABCB1—vagina—ovarian cancer	2.34e-05	0.00192	CbGeAlD
Cabazitaxel—ABCB1—testis—ovarian cancer	2.09e-05	0.00171	CbGeAlD
Cabazitaxel—Discomfort—Paclitaxel—ovarian cancer	1.85e-05	0.00068	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—ovarian cancer	1.85e-05	0.00068	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—ovarian cancer	1.84e-05	0.000677	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—ovarian cancer	1.84e-05	0.000676	CcSEcCtD
Cabazitaxel—Dry mouth—Paclitaxel—ovarian cancer	1.83e-05	0.000673	CcSEcCtD
Cabazitaxel—Diarrhoea—Vinorelbine—ovarian cancer	1.82e-05	0.000671	CcSEcCtD
Cabazitaxel—Dysgeusia—Docetaxel—ovarian cancer	1.82e-05	0.000671	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—ovarian cancer	1.82e-05	0.000668	CcSEcCtD
Cabazitaxel—Nausea—Melphalan—ovarian cancer	1.81e-05	0.000667	CcSEcCtD
Cabazitaxel—Confusional state—Paclitaxel—ovarian cancer	1.81e-05	0.000666	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—ovarian cancer	1.8e-05	0.000664	CcSEcCtD
Cabazitaxel—Back pain—Docetaxel—ovarian cancer	1.8e-05	0.000663	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—ovarian cancer	1.8e-05	0.000661	CcSEcCtD
Cabazitaxel—Oedema—Paclitaxel—ovarian cancer	1.79e-05	0.00066	CcSEcCtD
Cabazitaxel—Muscle spasms—Docetaxel—ovarian cancer	1.79e-05	0.000659	CcSEcCtD
Cabazitaxel—Infection—Paclitaxel—ovarian cancer	1.78e-05	0.000656	CcSEcCtD
Cabazitaxel—Dry skin—Doxorubicin—ovarian cancer	1.77e-05	0.000651	CcSEcCtD
Cabazitaxel—Dizziness—Vinorelbine—ovarian cancer	1.76e-05	0.000649	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—ovarian cancer	1.76e-05	0.000649	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—ovarian cancer	1.76e-05	0.000649	CcSEcCtD
Cabazitaxel—Nervous system disorder—Paclitaxel—ovarian cancer	1.76e-05	0.000647	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—ovarian cancer	1.76e-05	0.000647	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Paclitaxel—ovarian cancer	1.76e-05	0.000646	CcSEcCtD
Cabazitaxel—Tachycardia—Paclitaxel—ovarian cancer	1.75e-05	0.000644	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—ovarian cancer	1.74e-05	0.000642	CcSEcCtD
Cabazitaxel—Skin disorder—Paclitaxel—ovarian cancer	1.74e-05	0.000641	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	1.74e-05	0.00064	CcSEcCtD
Cabazitaxel—Anaemia—Docetaxel—ovarian cancer	1.72e-05	0.000634	CcSEcCtD
Cabazitaxel—Anorexia—Paclitaxel—ovarian cancer	1.71e-05	0.000629	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—ovarian cancer	1.71e-05	0.000629	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	1.7e-05	0.000627	CcSEcCtD
Cabazitaxel—Vomiting—Vinorelbine—ovarian cancer	1.7e-05	0.000624	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—ovarian cancer	1.69e-05	0.000621	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—ovarian cancer	1.69e-05	0.000621	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—ovarian cancer	1.68e-05	0.000618	CcSEcCtD
Cabazitaxel—Hypotension—Paclitaxel—ovarian cancer	1.68e-05	0.000617	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—ovarian cancer	1.68e-05	0.000617	CcSEcCtD
Cabazitaxel—Headache—Vinorelbine—ovarian cancer	1.67e-05	0.000615	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—ovarian cancer	1.67e-05	0.000614	CcSEcCtD
Cabazitaxel—Leukopenia—Docetaxel—ovarian cancer	1.67e-05	0.000614	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—ovarian cancer	1.67e-05	0.000613	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	1.63e-05	0.000601	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—ovarian cancer	1.63e-05	0.0006	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—ovarian cancer	1.63e-05	0.000599	CcSEcCtD
Cabazitaxel—Cough—Docetaxel—ovarian cancer	1.63e-05	0.000598	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—ovarian cancer	1.62e-05	0.000595	CcSEcCtD
Cabazitaxel—Paraesthesia—Paclitaxel—ovarian cancer	1.61e-05	0.000593	CcSEcCtD
Cabazitaxel—Hypertension—Docetaxel—ovarian cancer	1.61e-05	0.000592	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—ovarian cancer	1.61e-05	0.000592	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—ovarian cancer	1.61e-05	0.000592	CcSEcCtD
Cabazitaxel—Dyspnoea—Paclitaxel—ovarian cancer	1.6e-05	0.000588	CcSEcCtD
Cabazitaxel—Myalgia—Docetaxel—ovarian cancer	1.59e-05	0.000584	CcSEcCtD
Cabazitaxel—Chest pain—Docetaxel—ovarian cancer	1.59e-05	0.000584	CcSEcCtD
Cabazitaxel—Arthralgia—Docetaxel—ovarian cancer	1.59e-05	0.000584	CcSEcCtD
Cabazitaxel—Nausea—Vinorelbine—ovarian cancer	1.58e-05	0.000583	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—ovarian cancer	1.58e-05	0.000582	CcSEcCtD
Cabazitaxel—Dyspepsia—Paclitaxel—ovarian cancer	1.58e-05	0.000581	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—ovarian cancer	1.58e-05	0.00058	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	1.58e-05	0.00058	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—ovarian cancer	1.56e-05	0.000575	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—ovarian cancer	1.56e-05	0.000575	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—ovarian cancer	1.56e-05	0.000574	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—ovarian cancer	1.56e-05	0.000574	CcSEcCtD
Cabazitaxel—Decreased appetite—Paclitaxel—ovarian cancer	1.56e-05	0.000574	CcSEcCtD
Cabazitaxel—Dry mouth—Docetaxel—ovarian cancer	1.55e-05	0.000571	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—ovarian cancer	1.55e-05	0.000571	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.55e-05	0.00057	CcSEcCtD
Cabazitaxel—Fatigue—Paclitaxel—ovarian cancer	1.55e-05	0.000569	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—ovarian cancer	1.54e-05	0.000567	CcSEcCtD
Cabazitaxel—Constipation—Paclitaxel—ovarian cancer	1.53e-05	0.000564	CcSEcCtD
Cabazitaxel—Pain—Paclitaxel—ovarian cancer	1.53e-05	0.000564	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—ovarian cancer	1.53e-05	0.000564	CcSEcCtD
Cabazitaxel—Confusional state—Docetaxel—ovarian cancer	1.53e-05	0.000564	CcSEcCtD
Cabazitaxel—Oedema—Docetaxel—ovarian cancer	1.52e-05	0.000559	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—ovarian cancer	1.51e-05	0.00124	CbGeAlD
Cabazitaxel—Infection—Docetaxel—ovarian cancer	1.51e-05	0.000556	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—ovarian cancer	1.51e-05	0.000556	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—ovarian cancer	1.51e-05	0.000554	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—ovarian cancer	1.5e-05	0.000551	CcSEcCtD
Cabazitaxel—Nervous system disorder—Docetaxel—ovarian cancer	1.49e-05	0.000549	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Docetaxel—ovarian cancer	1.49e-05	0.000548	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—ovarian cancer	1.49e-05	0.000547	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—ovarian cancer	1.49e-05	0.000547	CcSEcCtD
Cabazitaxel—Tachycardia—Docetaxel—ovarian cancer	1.48e-05	0.000546	CcSEcCtD
Cabazitaxel—Feeling abnormal—Paclitaxel—ovarian cancer	1.48e-05	0.000544	CcSEcCtD
Cabazitaxel—Skin disorder—Docetaxel—ovarian cancer	1.48e-05	0.000543	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.47e-05	0.00054	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—ovarian cancer	1.46e-05	0.000538	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.46e-05	0.000537	CcSEcCtD
Cabazitaxel—Anorexia—Docetaxel—ovarian cancer	1.45e-05	0.000533	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—ovarian cancer	1.45e-05	0.000532	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—ovarian cancer	1.45e-05	0.000532	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—ovarian cancer	1.44e-05	0.000529	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—ovarian cancer	1.43e-05	0.000525	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—ovarian cancer	1.42e-05	0.000523	CcSEcCtD
Cabazitaxel—Hypotension—Docetaxel—ovarian cancer	1.42e-05	0.000523	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—ovarian cancer	1.42e-05	0.000522	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—ovarian cancer	1.42e-05	0.000522	CcSEcCtD
Cabazitaxel—Abdominal pain—Paclitaxel—ovarian cancer	1.42e-05	0.000522	CcSEcCtD
Cabazitaxel—Body temperature increased—Paclitaxel—ovarian cancer	1.42e-05	0.000522	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—ovarian cancer	1.41e-05	0.000521	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.39e-05	0.00051	CcSEcCtD
Cabazitaxel—Paraesthesia—Docetaxel—ovarian cancer	1.37e-05	0.000502	CcSEcCtD
Cabazitaxel—Dyspnoea—Docetaxel—ovarian cancer	1.36e-05	0.000499	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—ovarian cancer	1.35e-05	0.000496	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—ovarian cancer	1.35e-05	0.000495	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—ovarian cancer	1.34e-05	0.000493	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—ovarian cancer	1.34e-05	0.000493	CcSEcCtD
Cabazitaxel—Dyspepsia—Docetaxel—ovarian cancer	1.34e-05	0.000492	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—ovarian cancer	1.33e-05	0.000489	CcSEcCtD
Cabazitaxel—Decreased appetite—Docetaxel—ovarian cancer	1.32e-05	0.000486	CcSEcCtD
Cabazitaxel—Hypersensitivity—Paclitaxel—ovarian cancer	1.32e-05	0.000486	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—ovarian cancer	1.32e-05	0.000485	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—ovarian cancer	1.32e-05	0.000484	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.31e-05	0.000483	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—ovarian cancer	1.31e-05	0.000483	CcSEcCtD
Cabazitaxel—Fatigue—Docetaxel—ovarian cancer	1.31e-05	0.000482	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—ovarian cancer	1.31e-05	0.000482	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—ovarian cancer	1.31e-05	0.000482	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—ovarian cancer	1.3e-05	0.00048	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—ovarian cancer	1.3e-05	0.000479	CcSEcCtD
Cabazitaxel—Pain—Docetaxel—ovarian cancer	1.3e-05	0.000478	CcSEcCtD
Cabazitaxel—Constipation—Docetaxel—ovarian cancer	1.3e-05	0.000478	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—ovarian cancer	1.3e-05	0.000477	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—ovarian cancer	1.29e-05	0.000475	CcSEcCtD
Cabazitaxel—Asthenia—Paclitaxel—ovarian cancer	1.29e-05	0.000474	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—ovarian cancer	1.28e-05	0.000469	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—ovarian cancer	1.26e-05	0.000465	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—ovarian cancer	1.26e-05	0.000462	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—ovarian cancer	1.26e-05	0.000462	CcSEcCtD
Cabazitaxel—Feeling abnormal—Docetaxel—ovarian cancer	1.25e-05	0.000461	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—ovarian cancer	1.25e-05	0.000459	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—ovarian cancer	1.25e-05	0.000458	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Docetaxel—ovarian cancer	1.24e-05	0.000458	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—ovarian cancer	1.24e-05	0.000456	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—ovarian cancer	1.24e-05	0.000456	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—ovarian cancer	1.23e-05	0.000453	CcSEcCtD
Cabazitaxel—Diarrhoea—Paclitaxel—ovarian cancer	1.23e-05	0.000452	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—ovarian cancer	1.22e-05	0.000447	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—ovarian cancer	1.21e-05	0.000446	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—ovarian cancer	1.21e-05	0.000445	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—ovarian cancer	1.21e-05	0.000444	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—ovarian cancer	1.2e-05	0.000443	CcSEcCtD
Cabazitaxel—Abdominal pain—Docetaxel—ovarian cancer	1.2e-05	0.000442	CcSEcCtD
Cabazitaxel—Body temperature increased—Docetaxel—ovarian cancer	1.2e-05	0.000442	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—ovarian cancer	1.2e-05	0.000441	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—ovarian cancer	1.19e-05	0.000439	CcSEcCtD
Cabazitaxel—Dizziness—Paclitaxel—ovarian cancer	1.19e-05	0.000436	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—ovarian cancer	1.18e-05	0.000434	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—ovarian cancer	1.17e-05	0.000431	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—ovarian cancer	1.17e-05	0.000429	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—ovarian cancer	1.16e-05	0.000428	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—ovarian cancer	1.16e-05	0.000428	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—ovarian cancer	1.16e-05	0.000427	CcSEcCtD
Cabazitaxel—Vomiting—Paclitaxel—ovarian cancer	1.14e-05	0.00042	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—ovarian cancer	1.14e-05	0.000419	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—ovarian cancer	1.13e-05	0.000417	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—ovarian cancer	1.13e-05	0.000415	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—ovarian cancer	1.12e-05	0.000414	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—ovarian cancer	1.12e-05	0.000414	CcSEcCtD
Cabazitaxel—Headache—Paclitaxel—ovarian cancer	1.12e-05	0.000414	CcSEcCtD
Cabazitaxel—Hypersensitivity—Docetaxel—ovarian cancer	1.12e-05	0.000412	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—ovarian cancer	1.12e-05	0.000411	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—ovarian cancer	1.1e-05	0.000403	CcSEcCtD
Cabazitaxel—Asthenia—Docetaxel—ovarian cancer	1.09e-05	0.000401	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—ovarian cancer	1.08e-05	0.000399	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—ovarian cancer	1.08e-05	0.000397	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—ovarian cancer	1.07e-05	0.000395	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—ovarian cancer	1.07e-05	0.000394	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—ovarian cancer	1.07e-05	0.000394	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—ovarian cancer	1.07e-05	0.000394	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—ovarian cancer	1.07e-05	0.000392	CcSEcCtD
Cabazitaxel—Nausea—Paclitaxel—ovarian cancer	1.07e-05	0.000392	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.06e-05	0.000391	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—ovarian cancer	1.06e-05	0.000389	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—ovarian cancer	1.05e-05	0.000386	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—ovarian cancer	1.05e-05	0.000385	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—ovarian cancer	1.04e-05	0.000384	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—ovarian cancer	1.04e-05	0.000383	CcSEcCtD
Cabazitaxel—Diarrhoea—Docetaxel—ovarian cancer	1.04e-05	0.000383	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—ovarian cancer	1.03e-05	0.000381	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—ovarian cancer	1.03e-05	0.000377	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—ovarian cancer	1.02e-05	0.000375	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—ovarian cancer	1.01e-05	0.000373	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—ovarian cancer	1.01e-05	0.00037	CcSEcCtD
Cabazitaxel—Dizziness—Docetaxel—ovarian cancer	1.01e-05	0.00037	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—ovarian cancer	1e-05	0.000369	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—ovarian cancer	1e-05	0.000369	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—ovarian cancer	1e-05	0.000368	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—ovarian cancer	9.96e-06	0.000367	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—ovarian cancer	9.9e-06	0.000364	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—ovarian cancer	9.9e-06	0.000364	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—ovarian cancer	9.9e-06	0.000364	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—ovarian cancer	9.86e-06	0.000363	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.83e-06	0.000362	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—ovarian cancer	9.78e-06	0.00036	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—ovarian cancer	9.77e-06	0.00036	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—ovarian cancer	9.68e-06	0.000356	CcSEcCtD
Cabazitaxel—Vomiting—Docetaxel—ovarian cancer	9.67e-06	0.000356	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—ovarian cancer	9.58e-06	0.000353	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—ovarian cancer	9.57e-06	0.000352	CcSEcCtD
Cabazitaxel—Headache—Docetaxel—ovarian cancer	9.52e-06	0.000351	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—ovarian cancer	9.49e-06	0.000349	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—ovarian cancer	9.43e-06	0.000347	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.34e-06	0.000344	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—ovarian cancer	9.31e-06	0.000342	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—ovarian cancer	9.29e-06	0.000342	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—ovarian cancer	9.26e-06	0.000341	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—ovarian cancer	9.22e-06	0.000339	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—ovarian cancer	9.21e-06	0.000339	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—ovarian cancer	9.14e-06	0.000336	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—ovarian cancer	9.04e-06	0.000333	CcSEcCtD
Cabazitaxel—Nausea—Docetaxel—ovarian cancer	9.03e-06	0.000332	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—ovarian cancer	9.03e-06	0.000332	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—ovarian cancer	8.91e-06	0.000328	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—ovarian cancer	8.87e-06	0.000326	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.85e-06	0.000326	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—ovarian cancer	8.84e-06	0.000325	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—ovarian cancer	8.77e-06	0.000323	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—ovarian cancer	8.77e-06	0.000323	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.64e-06	0.000318	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—ovarian cancer	8.52e-06	0.000314	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—ovarian cancer	8.46e-06	0.000311	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—ovarian cancer	8.45e-06	0.000311	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—ovarian cancer	8.39e-06	0.000309	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—ovarian cancer	8.35e-06	0.000307	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—ovarian cancer	8.25e-06	0.000304	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.19e-06	0.000301	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—ovarian cancer	8.18e-06	0.000301	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—ovarian cancer	8.11e-06	0.000299	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—ovarian cancer	8.11e-06	0.000299	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—ovarian cancer	8.11e-06	0.000298	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—ovarian cancer	8.11e-06	0.000298	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—ovarian cancer	7.82e-06	0.000288	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.76e-06	0.000286	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—ovarian cancer	7.56e-06	0.000278	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—ovarian cancer	7.5e-06	0.000276	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—ovarian cancer	7.5e-06	0.000276	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—ovarian cancer	7.36e-06	0.000271	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—ovarian cancer	7.02e-06	0.000258	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—ovarian cancer	6.99e-06	0.000257	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—ovarian cancer	6.81e-06	0.000251	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—ovarian cancer	6.78e-06	0.00025	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—ovarian cancer	6.52e-06	0.00024	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—ovarian cancer	6.49e-06	0.000239	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—ovarian cancer	6.42e-06	0.000236	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—ovarian cancer	6.27e-06	0.000231	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—ovarian cancer	6.09e-06	0.000224	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—ovarian cancer	6.03e-06	0.000222	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—ovarian cancer	5.94e-06	0.000219	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—ovarian cancer	5.64e-06	0.000207	CcSEcCtD
Cabazitaxel—ABCB1—Allograft Rejection—IL2—ovarian cancer	4.11e-06	0.00026	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.05e-06	0.000256	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—MMP2—ovarian cancer	4.04e-06	0.000256	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MMP2—ovarian cancer	4.04e-06	0.000256	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—ovarian cancer	4.04e-06	0.000256	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	4.03e-06	0.000255	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.03e-06	0.000255	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.02e-06	0.000254	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	4e-06	0.000253	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—ovarian cancer	3.99e-06	0.000253	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.95e-06	0.00025	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.93e-06	0.000249	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.93e-06	0.000249	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MYC—ovarian cancer	3.92e-06	0.000248	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CXCL8—ovarian cancer	3.91e-06	0.000248	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—MMP2—ovarian cancer	3.9e-06	0.000247	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN1B—ovarian cancer	3.9e-06	0.000247	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.85e-06	0.000244	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYTB—ovarian cancer	3.84e-06	0.000243	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	3.84e-06	0.000243	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—MAPK3—ovarian cancer	3.82e-06	0.000242	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—MMP2—ovarian cancer	3.78e-06	0.000239	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.72e-06	0.000236	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—ovarian cancer	3.72e-06	0.000235	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NME2—ovarian cancer	3.7e-06	0.000234	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—MMP2—ovarian cancer	3.69e-06	0.000234	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—MAPK1—ovarian cancer	3.63e-06	0.00023	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	3.62e-06	0.000229	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—BRIP1—ovarian cancer	3.62e-06	0.000229	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—YAP1—ovarian cancer	3.62e-06	0.000229	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.61e-06	0.000229	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CTNNB1—ovarian cancer	3.61e-06	0.000228	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MAPK3—ovarian cancer	3.61e-06	0.000228	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.58e-06	0.000227	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—ovarian cancer	3.51e-06	0.000222	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.49e-06	0.000221	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.44e-06	0.000218	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—ovarian cancer	3.43e-06	0.000217	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MAPK1—ovarian cancer	3.43e-06	0.000217	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MAPK3—ovarian cancer	3.43e-06	0.000217	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—ovarian cancer	3.36e-06	0.000212	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—ovarian cancer	3.36e-06	0.000212	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—BRIP1—ovarian cancer	3.35e-06	0.000212	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPP1CC—ovarian cancer	3.35e-06	0.000212	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—ovarian cancer	3.33e-06	0.000211	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MMP2—ovarian cancer	3.32e-06	0.00021	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.3e-06	0.000209	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MAPK1—ovarian cancer	3.26e-06	0.000207	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.25e-06	0.000206	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—ovarian cancer	3.24e-06	0.000205	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN1B—ovarian cancer	3.23e-06	0.000204	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NME2—ovarian cancer	3.22e-06	0.000204	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.21e-06	0.000203	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.17e-06	0.000201	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—ovarian cancer	3.15e-06	0.0002	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.15e-06	0.000199	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.15e-06	0.000199	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—ovarian cancer	3.14e-06	0.000199	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.14e-06	0.000199	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.12e-06	0.000198	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CTNNB1—ovarian cancer	3.1e-06	0.000196	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CTNNB1—ovarian cancer	3.1e-06	0.000196	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—ovarian cancer	3.08e-06	0.000195	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—ovarian cancer	3.07e-06	0.000194	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MAPK3—ovarian cancer	3.07e-06	0.000194	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—ovarian cancer	3.05e-06	0.000193	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	3.05e-06	0.000193	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MMP2—ovarian cancer	3.03e-06	0.000192	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CTNNB1—ovarian cancer	2.99e-06	0.000189	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—ovarian cancer	2.98e-06	0.000189	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1B—ovarian cancer	2.95e-06	0.000187	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—FASN—ovarian cancer	2.95e-06	0.000187	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.94e-06	0.000186	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—ovarian cancer	2.92e-06	0.000185	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MAPK1—ovarian cancer	2.92e-06	0.000185	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	2.9e-06	0.000184	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CTNNB1—ovarian cancer	2.9e-06	0.000183	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.88e-06	0.000183	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—ovarian cancer	2.88e-06	0.000182	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.84e-06	0.00018	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CTNNB1—ovarian cancer	2.83e-06	0.000179	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—ovarian cancer	2.82e-06	0.000178	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	2.8e-06	0.000177	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—ovarian cancer	2.76e-06	0.000175	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—ovarian cancer	2.76e-06	0.000174	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYTB—ovarian cancer	2.75e-06	0.000174	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.74e-06	0.000174	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.7e-06	0.000171	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	2.69e-06	0.00017	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.64e-06	0.000167	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.6e-06	0.000165	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—ovarian cancer	2.58e-06	0.000163	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.57e-06	0.000163	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.56e-06	0.000162	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CTNNB1—ovarian cancer	2.54e-06	0.000161	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MAPK3—ovarian cancer	2.54e-06	0.000161	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—ovarian cancer	2.53e-06	0.00016	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—ovarian cancer	2.52e-06	0.00016	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.47e-06	0.000157	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—ovarian cancer	2.47e-06	0.000156	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—ovarian cancer	2.45e-06	0.000155	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—YAP1—ovarian cancer	2.43e-06	0.000154	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MAPK1—ovarian cancer	2.42e-06	0.000153	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.4e-06	0.000152	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—BRIP1—ovarian cancer	2.4e-06	0.000152	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPP1CC—ovarian cancer	2.4e-06	0.000152	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYTB—ovarian cancer	2.38e-06	0.000151	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	2.38e-06	0.000151	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.37e-06	0.00015	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.33e-06	0.000147	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CTNNB1—ovarian cancer	2.33e-06	0.000147	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MAPK3—ovarian cancer	2.32e-06	0.000147	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—ovarian cancer	2.26e-06	0.000143	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—YAP1—ovarian cancer	2.25e-06	0.000142	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.24e-06	0.000142	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ABCB1—ovarian cancer	2.21e-06	0.00014	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MAPK1—ovarian cancer	2.21e-06	0.00014	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TYMS—ovarian cancer	2.17e-06	0.000137	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.11e-06	0.000134	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.08e-06	0.000132	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.08e-06	0.000132	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.08e-06	0.000132	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYTB—ovarian cancer	2.07e-06	0.000131	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.07e-06	0.000131	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.03e-06	0.000129	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—ovarian cancer	2.03e-06	0.000128	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.01e-06	0.000127	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NME2—ovarian cancer	1.98e-06	0.000126	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—FASN—ovarian cancer	1.98e-06	0.000125	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.98e-06	0.000125	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.96e-06	0.000124	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.95e-06	0.000123	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.91e-06	0.000121	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.88e-06	0.000119	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—ovarian cancer	1.86e-06	0.000117	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.84e-06	0.000117	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—FASN—ovarian cancer	1.83e-06	0.000116	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.81e-06	0.000115	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BRIP1—ovarian cancer	1.81e-06	0.000115	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.8e-06	0.000114	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.8e-06	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.75e-06	0.000111	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.74e-06	0.00011	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.72e-06	0.000109	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.67e-06	0.000106	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.67e-06	0.000106	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.63e-06	0.000103	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—YAP1—ovarian cancer	1.61e-06	0.000102	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.6e-06	0.000101	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.59e-06	0.000101	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.59e-06	0.000101	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.59e-06	0.0001	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.55e-06	9.83e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.55e-06	9.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.52e-06	9.6e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.49e-06	9.41e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.48e-06	9.38e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.47e-06	9.28e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.46e-06	9.24e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.4e-06	8.87e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—YAP1—ovarian cancer	1.4e-06	8.84e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.38e-06	8.75e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ABCB1—ovarian cancer	1.38e-06	8.71e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMS—ovarian cancer	1.35e-06	8.55e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.35e-06	8.53e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—FASN—ovarian cancer	1.31e-06	8.32e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.3e-06	8.25e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.29e-06	8.18e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYTB—ovarian cancer	1.28e-06	8.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.25e-06	7.9e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	1.22e-06	7.73e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—YAP1—ovarian cancer	1.22e-06	7.7e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.21e-06	7.69e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.2e-06	7.58e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.18e-06	7.44e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—FASN—ovarian cancer	1.14e-06	7.21e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.12e-06	7.11e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.12e-06	7.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.12e-06	7.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.12e-06	7.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.1e-06	6.97e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAV1—ovarian cancer	1.09e-06	6.89e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.08e-06	6.85e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	1.07e-06	6.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.06e-06	6.72e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.06e-06	6.7e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—ovarian cancer	1.06e-06	6.68e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.04e-06	6.56e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—FASN—ovarian cancer	9.92e-07	6.28e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—ovarian cancer	9.92e-07	6.28e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—ovarian cancer	9.86e-07	6.24e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC5A5—ovarian cancer	9.75e-07	6.18e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—ovarian cancer	9.68e-07	6.13e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC2A1—ovarian cancer	9.42e-07	5.96e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	9.41e-07	5.96e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	9.19e-07	5.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.15e-07	5.79e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.03e-07	5.72e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—ovarian cancer	8.72e-07	5.52e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—ovarian cancer	8.54e-07	5.41e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—ovarian cancer	8.38e-07	5.31e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	8.21e-07	5.2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.01e-07	5.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAV1—ovarian cancer	7.8e-07	4.94e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—ovarian cancer	7.6e-07	4.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—YAP1—ovarian cancer	7.49e-07	4.75e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	7.45e-07	4.71e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—ovarian cancer	7.3e-07	4.62e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.1e-07	4.5e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—ovarian cancer	7.09e-07	4.49e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAV1—ovarian cancer	6.76e-07	4.28e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—ovarian cancer	6.57e-07	4.16e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.45e-07	4.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.25e-07	3.95e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.15e-07	3.9e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FASN—ovarian cancer	6.11e-07	3.87e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—ovarian cancer	6.08e-07	3.85e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.01e-07	3.8e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAV1—ovarian cancer	5.89e-07	3.73e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.8e-07	3.67e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.56e-07	3.52e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.44e-07	3.45e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.41e-07	3.43e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.36e-07	3.39e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	5e-07	3.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.93e-07	3.12e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.72e-07	2.99e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.71e-07	2.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—ovarian cancer	4.7e-07	2.98e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—ovarian cancer	4.63e-07	2.93e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.58e-07	2.9e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—ovarian cancer	4.5e-07	2.85e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.11e-07	2.6e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—ovarian cancer	4.09e-07	2.59e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—ovarian cancer	4.07e-07	2.58e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—ovarian cancer	3.78e-07	2.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAV1—ovarian cancer	3.63e-07	2.3e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—ovarian cancer	3.55e-07	2.25e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.32e-07	2.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.3e-07	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.9e-07	1.84e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.87e-07	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—ovarian cancer	2.71e-07	1.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.53e-07	1.6e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.5e-07	1.59e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—ovarian cancer	2.35e-07	1.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—ovarian cancer	2.19e-07	1.38e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—ovarian cancer	2.05e-07	1.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.54e-07	9.77e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—ovarian cancer	1.26e-07	7.98e-06	CbGpPWpGaD
